John W. Childs - 12 Aug 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Aug 2026, 18:01:54 UTC
Prior SEC filing
30 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Greco, Attorney-in-Fact

Key filing fact

John W. Childs filed Form 4 for Veradermics, Inc (MANE) on 14 Aug 2026.

Key facts

  • This page summarizes John W. Childs's Form 4 filing for Veradermics, Inc (MANE).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Aug 2026, 18:01.

Change

  • Previous filing in this sequence was filed on 30 Apr 2026.
  • Current net transaction value: -$10,711,700.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001027035 Primary reporting owner

CHILDS JOHN W

Relationship
Director
Address
C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
Signature
/s/ Michael Greco, Attorney-in-Fact
Signature date
14 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MANE transaction

Common Stock

Sale

Transaction value
$1,592,100
Shares
-15,000
Change %
-5.1%
Price
$106.14
Shares after
279,117
Date
12 Aug 2026
Ownership
See Footnote
Footnotes
F1, F2
MANE transaction

Common Stock

Sale

Transaction value
$8,578,400
Shares
-80,000
Change %
-29%
Price
$107.23
Shares after
199,117
Date
12 Aug 2026
Ownership
See Footnote
Footnotes
F2, F3
MANE transaction

Common Stock

Sale

Transaction value
$541,200
Shares
-5,000
Change %
-2.5%
Price
$108.24
Shares after
194,117
Date
12 Aug 2026
Ownership
See Footnote
Footnotes
F2
MANE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,907,889
Date
12 Aug 2026
Ownership
See Footnote
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.77 to $106.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

Shares held by the John W. Childs 2013 Revocable Trust. The Reporting Person is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.

Footnote F3

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.04 to $107.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F4

Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .